Processing of Silicon Nitride Bioceramics

Due to its tailorable composition and microstructure, silicon nitride (Si3N4) has emerged as a promising material with diverse applications ranging from precision high-speed bearings to biomedical implants. This review explores the manufacturing processes for silicon nitride components, highlighting key production methods such as reaction bonding (RBSN), hot-pressing (HPSN), sintering (SSN), gas-pressure sintering (GPSN), and hot-isostatic pressing (HIPSN). RBSN is a legacy, but still a frequently used process that involves the in situ nitridation of pre-formed silicon shapes. More recent processes require synthesized Si3N4 powders as the starting raw material. Powder synthesis methods include direct silicon powder nitridation, carbothermal silica reduction, and diimide decomposition, with the latter offering exceptional quality for biomedical implants. Upon receipt of Si3N4 raw materials, multiple additional manufacturing steps are required to produce useful components. Various types and amounts of sintering aids are combined with the Si3N4 powder, followed by mixing or comminution. Aqueous-based slurries are often employed to improve homogeneity, followed by spray- or freeze-drying. Component forming occurs by several methods, including dry- or isostatic-pressing, slip- or pressure-casting, extrusion, injection molding, and various additive manufacturing techniques. Densification is accomplished using any number of the aforementioned methods, but it is important to note that each technique has its own specific parameters and process requirements. Additional steps such as machining, polishing, proof testing, and non-destructive evaluation are well-established production or inspection processes. In vitro and in vivo animal studies demonstrate silicon nitride’s biocompatibility and its ability to promote osteoprogenitor cell differentiation and healing. These findings are further supported by clinical data on silicon nitride spinal fusion implants. Continuous research and clinical advancements position silicon nitride as a crucial biomaterial with the potential to significantly improve human health and functional outcomes.